Current through Register Vol. 54, No. 50, December 14, 2024
Section 1181a.30 - Prescription Drug Monitoring Program(a) A practitioner shall review the Prescription Drug Monitoring Program prior to issuing or modifying a patient certification to determine the controlled substance history of the patient to determine whether the controlled substance history of the patient would impact the patient's use of medical marijuana products.(b) A practitioner may access the Prescription Drug Monitoring Program to do any of the following: (1) Determine whether a patient may be under treatment with a controlled substance by another physician or other person.(2) Allow the practitioner to review the patient's controlled substance history as deemed necessary by the practitioner.(3) Provide to the patient, or caregiver if authorized by the patient, a copy of the patient's controlled substance history.Adopted by Pennsylvania Bulletin, Vol 53, No. 09. March 4, 2023, effective 3/4/2023